Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET

Eur J Nucl Med Mol Imaging. 2004 May;31(5):644-54. doi: 10.1007/s00259-003-1431-7. Epub 2004 Jan 17.

Abstract

Prior studies with anthropomorphic phantoms and single, static in vivo brain images have demonstrated that scatter correction significantly improves the accuracy of regional quantitation of single-photon emission tomography (SPET) brain images. Since the regional distribution of activity changes following a bolus injection of a typical neuroreceptor ligand, we examined the effect of scatter correction on the compartmental modeling of serial dynamic images of striatal and extrastriatal dopamine D(2) receptors using [(123)I]epidepride. Eight healthy human subjects [age 30+/-8 (range 22-46) years] participated in a study with a bolus injection of 373+/-12 (354-389) MBq [(123)I]epidepride and data acquisition over a period of 14 h. A transmission scan was obtained in each study for attenuation and scatter correction. Distribution volumes were calculated by means of compartmental nonlinear least-squares analysis using metabolite-corrected arterial input function and brain data processed with scatter correction using narrow-beam geometry micro (SC) and without scatter correction using broad-beam micro (NoSC). Effects of SC were markedly different among brain regions. SC increased activities in the putamen and thalamus after 1-1.5 h while it decreased activity during the entire experiment in the temporal cortex and cerebellum. Compared with NoSC, SC significantly increased specific distribution volume in the putamen (58%, P=0.0001) and thalamus (23%, P=0.0297). Compared with NoSC, SC made regional distribution of the specific distribution volume closer to that of [(18)F]fallypride. It is concluded that SC is required for accurate quantification of distribution volumes of receptor ligands in SPET studies.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adult
  • Benzamides / pharmacokinetics*
  • Brain / diagnostic imaging*
  • Brain / metabolism*
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / metabolism
  • Female
  • Humans
  • Image Enhancement / methods*
  • Image Interpretation, Computer-Assisted / methods*
  • Iodine Radioisotopes / pharmacokinetics
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Pyrrolidines / pharmacokinetics*
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Receptors, Dopamine D1 / metabolism*
  • Receptors, Dopamine D5
  • Reproducibility of Results
  • Scattering, Radiation
  • Sensitivity and Specificity
  • Tissue Distribution

Substances

  • Benzamides
  • DRD5 protein, human
  • Iodine Radioisotopes
  • Pyrrolidines
  • Radiopharmaceuticals
  • Receptors, Dopamine D1
  • epidepride
  • Receptors, Dopamine D5